Results 111 to 120 of about 191,459 (192)

Effects of an open-label placebo intervention on reactions to social exclusion in healthy adults: a randomized controlled trial. [PDF]

Sci Rep, 2023
Stumpp L, Jauch M, Sezer D, Gaab J, Greifeneder R.   +4 more
europepmc   +1 more source

Botulinum Toxin Treatment of Notalgia Paresthetica—A Critical Review and Update

Toxins
Notalgia paresthetica is a condition characterized by pruritus and pain in the upper back, often associated with skin discoloration in the same area.
Ava Grace Tohidian, Shahroo Etemadmoghadam, Bahman Jabbari   +2 more
doaj   +1 more source

Safety and efficacy of occipital nerve stimulation as treatment of chronic cluster headache: an investigator-initiated, double-blind, randomized, placebo-controlled study

The Journal of Headache and Pain
Background Occipital nerve stimulation has shown promising results in attack prevention in patients with chronic cluster headache, but evidence from controlled trials is scarce.
Ida Stisen Fogh-Andersen, Jens Christian Hedemann Sørensen, Anja Sofie Petersen, Rigmor Højland Jensen, Kaare Meier   +4 more
doaj   +1 more source

The safety and efficacy of extended use of an oral shape-shifting superabsorbent hydrogel capsule for weight loss: The ELECT extension study

Obesity Pillars
Background: Long-term weight-loss maintenance remains challenging despite of the numerous available treatments. The previously published pivotal randomized RESET study demonstrated a mean weight reduction from baseline of 6.6 % with Epitomee and a mean ...
Moshe Kamar, Donna H. Ryan, Sharon Leonard, Holly R. Wyatt, Yael Kenan, Liora Cohen Asaraf, Eti Ganon-Elazar, Jamy D. Ard   +7 more
doaj   +1 more source

The roles of expectation, comparator, administration route, and population in open-label placebo effects: a network meta-analysis. [PDF]

Sci Rep, 2023
Buergler S, Sezer D, Gaab J, Locher C.
europepmc   +1 more source

A randomized trial that compared brain activity, efficacy and plausibility of open-label placebo treatment and cognitive repappraisal for reducing emotional distress. [PDF]

Sci Rep, 2023
Schienle A, Kogler W, Wabnegger A.
europepmc   +1 more source

Author Correction: A randomized trial that compared brain activity, efficacy and plausibility of open-label placebo treatment and cognitive reappraisal for reducing emotional distress. [PDF]

Sci Rep, 2023
Schienle A, Kogler W, Wabnegger A.
europepmc   +1 more source

Efficacy of open-label placebos for premenstrual syndrome: a randomised controlled trial

BMJ Evidence-Based Medicine
ObjectiveTo investigate the efficacy and safety of open-label placebos (OLP) in premenstrual syndrome (PMS).DesignRandomised controlled trial.SettingSwitzerland, 2018–2020.Participants150 women (18–45 years of age) with PMS or premenstrual dysphoric disorder.InterventionRandom assignment (1:1:1) to treatment as usual (TAU), OLP without treatment ...
Antje Frey Nascimento, Jens Gaab, Bojana Degen, Mareike Rytz, Anja Holder, Dilan Sezer, Sarah Buergler, Andrea H Meyer, Irving Kirsch, Joe Kossowsky, Cosima Locher   +10 more
openaire   +2 more sources

Open-Label Placebo Effects on Psychological and Physical Well-Being: A Conceptual Replication Study. [PDF]

Clin Psychol Eur, 2022
Bräscher AK, Ferti IE, Witthöft M.
europepmc   +1 more source

Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]. [PDF]

BMC Psychiatry, 2023
Müller A, Konigorski S, Meißner C, Fadai T, Warren CV, Falkenberg I, Kircher T, Nestoriuc Y.   +7 more
europepmc   +1 more source